|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
1995-12-28
|
|
pubmed:abstractText |
This study sought to evaluate the hemodynamic effects of intravenous sematilide hydrochloride, a selective class III antiarrhythmic agent, in patients with heart failure and left ventricular systolic dysfunction.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0735-1097
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
26
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1679-84
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:7594103-Adult,
pubmed-meshheading:7594103-Aged,
pubmed-meshheading:7594103-Anti-Arrhythmia Agents,
pubmed-meshheading:7594103-Depression, Chemical,
pubmed-meshheading:7594103-Dose-Response Relationship, Drug,
pubmed-meshheading:7594103-Electrocardiography,
pubmed-meshheading:7594103-Female,
pubmed-meshheading:7594103-Heart Failure,
pubmed-meshheading:7594103-Hemodynamics,
pubmed-meshheading:7594103-Humans,
pubmed-meshheading:7594103-Infusions, Intravenous,
pubmed-meshheading:7594103-Male,
pubmed-meshheading:7594103-Middle Aged,
pubmed-meshheading:7594103-Procainamide
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Hemodynamic effects of intravenous sematilide in patients with congestive heart failure: a class III antiarrhythmic agent without cardiodepressant effects.
|
|
pubmed:affiliation |
Division of Cardiology, Medical College of Virginia, Richmond, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|
